VivoSeq
Other

Elective

0

Pipeline Programs↗

7

Active Trials↗

4

Companies Involved↗

Elective is an early-stage landscape with 0 programs across 4 companies. The most active players are Sunshine Lake Pharma Co., Ltd., Beijing Pearl Biotechnology Limited Liability Company, Novartis.

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

77/100

Attrition Rate

16/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Sunshine Lake Pharma Co., Ltd. logo

Sunshine Lake Pharma Co., Ltd.

0 programs

PreclinicalB

Beijing Pearl Biotechnology Limited Liability Company

0 programs

PreclinicalNovartis logo

Novartis

0 programs

PreclinicalM

MingSight Pharmaceuticals, Inc

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

45

clinical trials

Completed23 · 51%
Unknown status8 · 18%
Terminated4 · 9%
Withdrawn3 · 7%
Not yet recruiting2 · 4%
Recruiting2 · 4%
Other3 · 7%

Clinical Trials

Trial Activity

45 trials

Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder
Recruiting·JJohns Hopkins University·Phase 4·NCT06704594·288 enrolled
Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)
Recruiting·—·N/A·NCT07239791·160 enrolled
Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery.
Active, not recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 3·NCT06772272·158 enrolled
Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML
Active, not recruiting·—·Phase 1·NCT02091245·16 enrolled
Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section
Not yet recruiting·—·Phase 4·NCT06946589·200 enrolled
Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI
Not yet recruiting·TTanta University·Phase 3·NCT06870370·60 enrolled
To Evaluate Effect of Nebulized Dexmedetomedine Upon Blunting Autonomic Response of Laeyngoscopy and Intubation in Patients Undergoing Elective Intubation
Enrolling by invitation·—·N/A·NCT07480304·36 enrolled
Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
Completed·AAzienda Ospedaliera Universitaria Integrata Verona·Phase 4·NCT03779789·362 enrolled
Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF
Completed·NNational Cardiovascular Center Harapan Kita Hospital Indonesia·Phase 3·NCT04560309·60 enrolled
Spinal Anaesthesia With Chloroprocaine HCl 1% for Elective Lower Limb Procedures of Short Duration.
Completed·SSintetica SA·Phase 2·NCT02481505·45 enrolled
IINB vs. QLB for Elective Open Inguinal Herniorrhaphy
Completed·WWake Forest University Health Sciences·Phase 2·NCT03007966·60 enrolled
The Effect of the Anticholinergic Burden Following Elective Coronary Artery Surgery
Completed·—·Phase 4·NCT06349057·120 enrolled
Implantation Enhancement by Elective Cryopreservation of All Viable Embryos
Completed·UUniversitair Ziekenhuis Brussel·N/A·NCT02148393·212 enrolled
Persantin Preceding Elective PCI
Completed·RRadboud University Medical Center·Phase 4·NCT00767663·30 enrolled
Minimum Effective Volume for Selective Trunk Block
Completed·—·N/A·NCT04773405·25 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)